Organisation paid for research Program year 2019 Source: CMS Open Payments

Aspirus Cardiovascular Associates

Neither a doctor nor a teaching hospital

Research payments

$79,252

69 payments

Through program year 2019, Aspirus Cardiovascular Associates is reported as receiving $79,252 in research payments, across 69 payments.

By program year

1 row
Year Kind Amount Payments
2019 Research $79,252 69

Breakdown

Who paid Research payments · program year 2019
  1. Boehringer Ingelheim Pharma GmbH & Co.KG $58,962 12 payments
  2. Boehringer Ingelheim International GmbH $19,931 54 payments
  3. Boehringer Ingelheim France S.A.S. $359 3 payments
Studies the money was for Research payments · program year 2019
  1. Empagliflozin and heart failure (HFpEF) $78,892 66 payments
  2. Exercise capacity study in HFrEF $359 3 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record